Is ajantapharma.com Safe? Security Analysis for Ajanta Pharma Limited
http://ajantapharma.comCheck if ajantapharma.com is a scam or legitimate. Free security scan and reviews.
Above Healthcare avg (65)
10,000+
Domains scanned
500+
Security teams trust us
EveryPay
Secure checkout
Instant
Reports delivered
Get the professional PDF report for ajantapharma.com
Export this security analysis as a professional PDF document, receive it via email, and access marketing intelligence data including contact emails and phone numbers. One-time purchase for lifetime access.
PDF Report & Export
PDF download, email delivery, unlock code
Marketing Intelligence
Contact emails, phone numbers & warm leads
Plan Comparison
| Feature | PDF Report | Marketing+ |
|---|---|---|
| Full security analysis | ||
| Professional PDF export | ||
| Email delivery | ||
| Lifetime access + unlock code | ||
| Contact emails & phones | — | |
| Marketing outreach data | — |
Already purchased?
Order summary
Digital reports are delivered immediately after payment. By continuing you acknowledge the withdrawal waiver described in our Returns & Refunds policy.
Secure payments processed via EveryPay. Prices in EUR; Incl. 21% VAT.
SEQ SIA
Lastadijas 12 k-3, Riga, Latvia, LV-1050
Reg. No. 40203410806 • VAT LV40203410806
Support: guard@offseq.com • +371 2256 5353
AI Summary
Ajanta Pharma Limited is a specialty pharmaceutical company operating globally with a presence in over 30 countries. The company focuses on manufacturing and marketing branded generics, generics in the USA, and institutional business in Africa. Their R&D capabilities are robust, with over 850 scientists developing complex pharmaceutical products. The website reflects a professional and consistent brand image with comprehensive business and investor information. Technically, the site uses modern frontend technologies including Bootstrap, jQuery, Swiper.js, and Google Analytics, ensuring a responsive and user-friendly experience. Security posture is generally good with HTTPS enabled and use of Google reCAPTCHA, but lacks some security headers and explicit cookie consent mechanisms. WHOIS data is unavailable, which raises some concerns about domain registration transparency but does not detract significantly from the overall legitimacy given the professional web presence. Strategic recommendations include enhancing security headers, adding cookie consent, publishing vulnerability disclosure information, and improving incident response transparency.
Detected Technologies
10 urgent findings need attention
10 high
- + 2 more findings in the full report below
Keep ajantapharma.com under constant watch
Guard tracks your live infrastructure daily: certificate expiry, DNS & mail authentication drift, uptime changes, subdomain inventory, and unexpected tracker or content shifts. A full timeline captures every diff so you can prove remediation and spot regressions instantly.
Security drift alerts
Risk score drops, new high-severity issues, and header hardening gaps
Compliance watch
GDPR / NIS2 posture changes with governance evidence snapshots
Infrastructure surface
Unexpected open services, SSL expiry, DNS & email authentication changes
Content & tracker intelligence
Marketing tech shifts, analytics drift, and AI recommendation updates
Cancel anytime. Alerts sent to the contacts you choose. Unlock the full report to view historical timelines and alerts.
Security Headers
6 findings
35/100
GDPR Compliance
3 findings
58/100
NIS2 Compliance
9 findings
2/100
Email Security
3 findings
85/100
🧠AI Business Intelligence
Technology stack, business insights, and market analysis powered by AI.
Business Intelligence
Market & Strategic Analysis
Ajanta Pharma holds a strong market position in the pharmaceutical sector with leadership in multiple therapeutic segments. Their business model centers on specialty pharmaceuticals with a diversified product portfolio targeting branded generics and generics markets globally. The company targets healthcare professionals, investors, and partners, emphasizing innovation and quality manufacturing. The website's investor relations and corporate governance sections indicate a mature corporate structure. The absence of direct contact emails or phone numbers on the site suggests a controlled communication approach, likely to manage inquiries through forms. The company leverages digital marketing and analytics tools to monitor user engagement and optimize outreach. Overall, Ajanta Pharma demonstrates a solid business foundation with growth potential in emerging and established markets.
Security Posture Analysis
Comprehensive Security Assessment
The website employs HTTPS and Google reCAPTCHA to secure user interactions, indicating a baseline security awareness. However, the lack of visible security headers such as Content-Security-Policy and Strict-Transport-Security reduces the overall security hardening. No vulnerability disclosure or incident response contacts are published, which limits transparency and preparedness for security incidents. The absence of cookie consent mechanisms may pose compliance risks under GDPR and similar regulations. No exposed sensitive data or vulnerable libraries were detected in the HTML content. Overall, the security posture is moderate but could be significantly improved by implementing recommended best practices and compliance measures.
Strategic Recommendations
Priority Actions for Security Improvement
Implement comprehensive security headers including Content-Security-Policy, X-Content-Type-Options, X-Frame-Options, and Strict-Transport-Security.
✨Observations
AI-powered comprehensive website and business analysis.
AI-Enhanced Website Analysis
Business Insights
Ajanta Pharma Limited
Ajanta Pharma is a specialty pharmaceutical company providing quality medicines across 30+ countries. It has leadership in multiple molecules and therapeutic segments through first-to-market products. The company focuses on branded generics, generics in the USA, institution business in Africa, and has strong R&D and manufacturing capabilities.
good
consistent
Technical Stack
moderate
good
basic
good
Security Assessment
- HTTPS enabled
- Use of Google reCAPTCHA on forms
- No exposed sensitive data in HTML
Analytics & Tracking
Advertising & Marketing
Website Quality Assessment
Key Observations
Website is fully accessible with rich content and navigation
Get this report delivered to your inbox
Receive a summary of the ajantapharma.com security findings by email. Quick and easy to share with decision makers.
🛡️Security Headers
HTTP security headers analysis and recommendations.
Security Headers
HTTP security headers analysis
Missing Strict-Transport-Security header
HIGHForces HTTPS connections
Missing X-Content-Type-Options header
MEDIUMPrevents MIME type sniffing
Missing Content-Security-Policy header
HIGHControls resources the browser is allowed to load
Missing X-XSS-Protection header
MEDIUMLegacy XSS protection (deprecated but still recommended)
Missing Referrer-Policy header
LOWControls referrer information sent with requests
Missing Permissions-Policy header
MEDIUMControls browser features and APIs
👤GDPR Compliance
Privacy and data protection assessment under GDPR regulations.
GDPR Compliance
Privacy and data protection assessment
No Cookie Policy found
HIGHGDPR requires clear information about cookie usage
No Cookie Consent Banner found
HIGHGDPR requires explicit consent for non-essential cookies
Privacy policy may not be GDPR compliant
MEDIUMPrivacy policy lacks explicit GDPR compliance elements
GDPR Compliance Analysis
🛡️NIS2 Compliance
Network & Information Security Directive compliance assessment.
NIS2 Compliance
Network & Information Security Directive
No information security framework found
HIGHNIS2 requires documented cybersecurity and information security measures
No vulnerability disclosure policy
MEDIUMNIS2 encourages coordinated vulnerability disclosure
No security policy documentation found
HIGHNIS2 requires documented cybersecurity governance and risk management
No incident response procedures found
HIGHNIS2 requires documented incident response and business continuity plans
No business continuity planning found
MEDIUMNIS2 emphasizes operational resilience and business continuity
No security contact information
HIGHNIS2 requires clear incident reporting channels
No vulnerability reporting mechanism
MEDIUMClear vulnerability reporting supports coordinated disclosure
No NIS2 reference found
LOWConsider explicitly mentioning NIS2 compliance efforts
Critical sector without clear security compliance
HIGHDetected sectors: transport, banking, health, digital
Need this report as a PDF?
Download the complete ajantapharma.com security analysis as a professional PDF. Share it with your team, clients, or stakeholders.
📧Email Security
SPF, DKIM, and DMARC validation and email security assessment.
Email Security
SPF, DKIM, and DMARC validation
No BIMI Record
LOWBIMI displays brand logos in email clients
No MTA-STS Policy
MEDIUMMTA-STS enforces TLS for email delivery
No TLS-RPT Record
LOWTLS-RPT provides reporting for email TLS issues
SPF Details
DKIM Selectors Found
DMARC Details
🏆SSL/TLS Security
Certificate validity and encryption analysis.
SSL/TLS Security
Certificate validity and encryption analysis
Weak Protocols Supported
HIGHServer supports weak protocols: TLSv1.1
OCSP Stapling Not Enabled
LOWOCSP stapling improves performance and privacy
Certificate Transparency Not Implemented
LOWCertificate is not logged in Certificate Transparency logs
Partial SSL/TLS Assessment
LOWCompleted 3 of 4 security checks due to time constraints
Protocol Support
OCSP Status
📊DNS Health
DNS configuration and security assessment.
DNS Health
DNS configuration and security assessment
DNSSEC Not Enabled
MEDIUMDNSSEC is not configured for this domain
CAA Records Not Configured
LOWCertificate Authority Authorization (CAA) records not found
Domain Delete Lock Not Enabled
LOWDomain can be deleted without additional verification
Domain Registration Details
DNS Records
DNSSEC Status
DNS Performance
SPF Analysis
⚡Network Security
Port scanning and network exposure analysis.
Network Security
Port scanning and network exposure analysis
Good Network Security Posture
LOWNo unnecessary services detected on common risky ports
How does ajantapharma.com compare?
See how ajantapharma.com stacks up against similar websites in the same industry.
🔧Technical Analysis
Detailed technical findings and analysis from AI assessment.
Technical Analysis
Comprehensive security assessment findings
Additional Findings
Download the ajantapharma.com report as PDF
Get the complete analysis in a shareable PDF format, delivered instantly to your email with lifetime access.
PDF Report & Export
PDF download, email delivery, unlock code
Marketing Intelligence
Contact emails, phone numbers & warm leads
Plan Comparison
| Feature | PDF Report | Marketing+ |
|---|---|---|
| Full security analysis | ||
| Professional PDF export | ||
| Email delivery | ||
| Lifetime access + unlock code | ||
| Contact emails & phones | — | |
| Marketing outreach data | — |
Already purchased?
Order summary
Digital reports are delivered immediately after payment. By continuing you acknowledge the withdrawal waiver described in our Returns & Refunds policy.
Secure payments processed via EveryPay. Prices in EUR; Incl. 21% VAT.
SEQ SIA
Lastadijas 12 k-3, Riga, Latvia, LV-1050
Reg. No. 40203410806 • VAT LV40203410806
Support: guard@offseq.com • +371 2256 5353
Scan your own website
Liked the ajantapharma.com report? Run the same comprehensive security analysis on your domain — free, instant, and no sign-up required.
Or browse our directory of >10,000 scanned websites.
How did we do?
Your feedback directly shapes our roadmap. Rate the quality of this report, leave an optional comment, and let us know if you want our security specialists to follow up.
What others say about ajantapharma.com
Share your experience to help others make informed decisions. We verify every review by email and publish it once our moderation team approves it.
Community rating
—out of 5
0 reviews published